LBTSF (Almirall) Cyclically Adjusted Revenue per Share: $8.37 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LBTSF Almirall SA LBTSF
85 GF Score
Price $15.35
GF Value $17.57
! 2 Warning Signs
View Full Analysis

What is Almirall Cyclically Adjusted Revenue per Share?

Almirall LBTSF 85 Cyclically Adjusted Revenue per Share is $8.37 as of Jun. 2026. GuruFocus rates LBTSF with a GF Score™ of 85/100 and a GF Value™ of $17.57. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Almirall's adjusted revenue per share for the three months ended in Jun. 2026 was $1.643. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $8.37 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Almirall's average Cyclically Adjusted Revenue Growth Rate was 4.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 3.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Almirall was 4.50% per year. The lowest was 2.00% per year. And the median was 3.25% per year.

As of today (2026-07-31), Almirall's current stock price is $15.35. Almirall's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was $8.37. Almirall's Cyclically Adjusted PS Ratio of today is 1.83.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Almirall was 3.94. The lowest was 1.35. And the median was 2.04.


Almirall  (OTCPK:LBTSF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Almirall's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=15.35/8.37
=1.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Almirall was 3.94. The lowest was 1.35. And the median was 2.04.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Almirall Cyclically Adjusted Revenue per Share Related Terms


Almirall Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Almirall's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Almirall Cyclically Adjusted Revenue per Share Chart

Almirall Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.57 5.88 6.06 6.38 7.28

Almirall Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.36 6.80 7.28 7.71 8.37

LBTSF vs ZTS, UTHR, VTRS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Almirall's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Almirall Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Almirall's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Almirall's Cyclically Adjusted PS Ratio falls into.


LBTSF
85GF Score
Almirall SA LBTSF
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Almirall Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Almirall's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.643/130.5100*130.5100
=1.643

Current CPI (Jun. 2026) = 130.5100.

Almirall Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 1.219 99.737 1.595
201612 1.101 101.842 1.411
201703 1.172 100.896 1.516
201706 0.903 101.848 1.157
201709 1.060 101.524 1.363
201712 1.075 102.975 1.362
201803 1.315 102.122 1.681
201806 1.143 104.165 1.432
201809 1.168 103.818 1.468
201812 1.410 104.193 1.766
201903 1.394 103.488 1.758
201906 1.315 104.612 1.641
201909 1.295 103.905 1.627
201912 6.834 105.015 8.493
202003 1.528 103.469 1.927
202006 1.238 104.254 1.550
202009 1.221 103.521 1.539
202012 1.323 104.456 1.653
202103 1.475 104.857 1.836
202106 1.389 107.102 1.693
202109 1.240 107.669 1.503
202112 1.319 111.298 1.547
202203 1.404 115.153 1.591
202206 1.272 118.044 1.406
202209 1.017 117.221 1.132
202212 1.340 117.650 1.486
202303 1.372 118.948 1.505
202306 1.209 120.278 1.312
202309 1.064 121.343 1.144
202312 1.146 121.300 1.233
202403 1.293 122.762 1.375
202406 1.254 124.409 1.316
202409 1.199 123.121 1.271
202412 1.922 124.753 2.011
202503 1.450 125.531 1.508
202506 1.475 127.251 1.513
202509 1.424 126.840 1.465
202512 2.904 128.400 2.952
202603 1.575 129.860 1.583
202606 1.643 130.510 1.643

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $8.37 mean?
Almirall (LBTSF) has a Cyclically Adjusted Revenue per Share of $8.37 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Almirall and its competitors.
Is Almirall's Cyclically Adjusted Revenue per Share too high?
Almirall's current Cyclically Adjusted Revenue per Share is $8.37. Overall, Almirall has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Almirall's Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
Almirall's Cyclically Adjusted Revenue per Share of $8.37 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Almirall and its competitors. Almirall's current Cyclically Adjusted Revenue per Share is $8.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almirall stock overvalued right now?
Almirall (LBTSF) has a current Cyclically Adjusted Revenue per Share of $8.37. The stock's GF Value™ is $17.57, compared to a current price of $15.35 — trading 12.6% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $8.37. Almirall's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Almirall (LBTSF), the current Cyclically Adjusted Revenue per Share is $8.37 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Almirall (LBTSF) Overvalued in 2026?

Based on GuruFocus' analysis, Almirall stock appears to be undervalued. The current stock price of $15.35 is trading 12.6% below its estimated GF Value™ of $17.57.

Key valuation signals for LBTSF:

  • Cyclically Adjusted Revenue per Share: $8.37
  • GF Value™: $17.57 vs. price of $15.35 (12.6% below fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the LBTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Almirall Business Description

Other Exchanges 0O9B:UKALM:SpainE2Z:Germany
Address Ronda General Mitre 151, Barcelona, ESP, 08022
Almirall SA is a skin-health focused pharmaceutical company based in Barcelona and the parent company of a group engaged in the purchase, manufacture, storage, marketing, and mediation in the sale of pharmaceutical specialities and products, as well as related raw materials. The Group applies science to provide medical solutions focused on skin health diseases and partners with healthcare professionals, and its activities also include cosmetics; chemical, biotechnological and diagnostic products for human, veterinary, agrochemical and food use; instruments and accessories for the chemical, pharmaceutical and clinical industry; and research on active chemical and pharmaceutical ingredients and products.
85GF Score

Get the complete analysis for LBTSF

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.35
Price
$17.57
GF Value